Tag Archives: Colesevelam

CI & Patent News: 22/11/2010

1) Paragraph IV Litigation: Impax Confirms Patent Challenge Relating to WELCHOL® (Colesevelam HCl) for Oral Suspension, 3.75 gm/packet and 1.875 gm/packet (Link). Colesevelam is bile acid sequestrant.  Genzyme is originator for Colesevelam and is marketed by Daiichi sankyo in USA. Colesevelam is co … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment